Literature DB >> 18095218

Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid.

Gabriele Trauner1, Sophia Khom, Igor Baburin, Birgit Benedek, Steffen Hering, Brigitte Kopp.   

Abstract

Valeriana Officinalis L . is a traditionally used sleep remedy, however, the mechanism of action and the substances responsible for its sedative and sleep-enhancing properties are not fully understood. As we previously identified valerenic acid as a subunit-specific allosteric modulator of GABAA receptors, we now investigated the relation between modulation of GABAA receptors by Valerian extracts of different polarity and the content of sesquiterpenic acids (valerenic acid, acetoxyvalerenic acid). All extracts were analysed by HPLC concerning the content of sesquiterpenic acids. GABAA receptors composed of alpha 1, beta 2 and gamma 2S subunits were expressed in Xenopus laevis oocytes and the modulation of chloride currents through GABAA receptors (IGABA) by Valerian extracts was investigated using the two-microelectrode voltage clamp technique. Apolar extracts induced a significant enhancement of IGABA, whereas polar extracts showed no effect. These results were confirmed by fractionating a highly active ethyl acetate extract: again fractions with high contents of valerenic acid exhibited strong receptor activation. In addition, removal of sesquiterpenic acids from the ethyl acetate extract led to a loss of I (GABA) enhancement. In conclusion, our data show that the extent of GABAA receptor modulation by Valerian extracts is related to the content of valerenic acid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18095218     DOI: 10.1055/s-2007-993761

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  18 in total

Review 1.  Was Hawan Designed to Fight Anxiety-Scientific Evidences?

Authors:  R K Romana; A Sharma; V Gupta; R Kaur; S Kumar; P Bansal
Journal:  J Relig Health       Date:  2020-02

2.  Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease.

Authors:  Diêgo Madureira de Oliveria; George Barreto; Deyse Valverde G De Andrade; Ezequiel Saraceno; Laura Aon-Bertolino; Francisco Capani; Ramon Dos Santos El Bachá; Lisandro Diego Giraldez
Journal:  Neurochem Res       Date:  2008-05-30       Impact factor: 3.996

3.  Insights into structure-activity relationship of GABAA receptor modulating coumarins and furanocoumarins.

Authors:  Judith Singhuber; Igor Baburin; Gerhard F Ecker; Brigitte Kopp; Steffen Hering
Journal:  Eur J Pharmacol       Date:  2011-07-05       Impact factor: 4.432

4.  Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.

Authors:  Niteeka Maroo; Avijit Hazra; Tapas Das
Journal:  Indian J Pharmacol       Date:  2013 Jan-Feb       Impact factor: 1.200

Review 5.  Dietary and botanical anxiolytics.

Authors:  Elham Alramadhan; Mirna S Hanna; Mena S Hanna; Todd A Goldstein; Samantha M Avila; Benjamin S Weeks
Journal:  Med Sci Monit       Date:  2012-04

6.  Herbal Insomnia Medications that Target GABAergic Systems: A Review of the Psychopharmacological Evidence.

Authors:  Yuan Shi; Jing-Wen Dong; Jiang-He Zhao; Li-Na Tang; Jian-Jun Zhang
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

7.  The anxiolytic effects of a Valerian extract is based on valerenic acid.

Authors:  Axel Becker; Falko Felgentreff; Helmut Schröder; Beat Meier; Axel Brattström
Journal:  BMC Complement Altern Med       Date:  2014-07-28       Impact factor: 3.659

8.  Reversal of pentylenetetrazole-altered swimming and neural activity-regulated gene expression in zebrafish larvae by valproic acid and valerian extract.

Authors:  Bianca A Torres-Hernández; Luis R Colón; Coral Rosa-Falero; Aranza Torrado; Nahira Miscalichi; José G Ortíz; Lorena González-Sepúlveda; Naydi Pérez-Ríos; Erick Suárez-Pérez; John N Bradsher; Martine Behra
Journal:  Psychopharmacology (Berl)       Date:  2016-05-11       Impact factor: 4.530

Review 9.  Valerian: no evidence for clinically relevant interactions.

Authors:  Olaf Kelber; Karen Nieber; Karin Kraft
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-30       Impact factor: 2.629

10.  SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson.

Authors:  Gesivaldo Santos; Lisandro Diego Giraldez-Alvarez; Marco Ávila-Rodriguez; Francisco Capani; Eduardo Galembeck; Aristóteles Gôes Neto; George E Barreto; Bruno Andrade
Journal:  Front Aging Neurosci       Date:  2016-05-02       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.